RCM
MRK icon

Raleigh Capital Management’s Merck MRK Stock Holding History

Raleigh Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
15,000
+122
+0.8% +$14.3K 0.62% 51
2026
Q1 		$1.79M Buy
14,878
+3,412
+30% +$394K 0.62% 51
2025
Q4 		$1.21M Buy
11,466
+6,065
+112% +$569K 0.44% 67
2025
Q3 		$453K Sell
5,401
-734
-12% -$60.5K 0.17% 126
2025
Q2 		$486K Sell
6,135
-165
-3% -$13.1K 0.2% 125
2025
Q1 		$565K Sell
6,300
-6,614
-51% -$618K 0.26% 107
2024
Q4 		$1.28M Sell
12,914
-557
-4% -$57.4K 0.5% 62
2024
Q3 		$1.53M Buy
13,471
+463
+4% +$55K 0.59% 52
2024
Q2 		$1.61M Buy
13,008
+279
+2% +$35.9K 0.69% 43
2024
Q1 		$1.68M Buy
12,729
+491
+4% +$60.5K 0.72% 41
2023
Q4 		$1.33M Sell
12,238
-6
-0% -$623 0.62% 47
2023
Q3 		$1.26M Sell
12,244
-2,111
-15% -$228K 0.64% 52
2023
Q2 		$1.66M Sell
14,355
-291
-2% -$33K 0.83% 38
2023
Q1 		$1.56M Sell
14,646
-7,175
-33% -$775K 0.77% 39
2022
Q4 		$2.42M Sell
21,821
-6,698
-23% -$685K 1.26% 19
2022
Q3 		$2.46M Sell
28,519
-154
-0.5% -$13.7K 1.44% 9
2022
Q2 		$2.61M Buy
28,673
+2,256
+9% +$200K 1.49% 9
2022
Q1 		$2.17M Buy
26,417
+3,684
+16% +$290K 1.18% 14
2021
Q4 		$1.74M Buy
+22,733
New +$1.81M 1.78% 12

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Raleigh Capital Management's MRK Position: Q2 2026 in Review

Raleigh Capital Management increased its Merck (MRK) stake by 0.82% in Q2 2026, buying an estimated $14.3K and bringing the position to 15,000 shares worth $1.93M. The position accounts for 0.62% of the portfolio, ranked #51.

Raleigh Capital Management first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.61M in Q2 2022. 1,038 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Raleigh Capital Management held 15,000 shares of Merck worth $1.93M as of Q2 2026.
  • Raleigh Capital Management bought 122 Merck shares in Q2 2026, an estimated $14.3K.
  • Merck made up 0.62% of Raleigh Capital Management's portfolio in Q2 2026, its #51 holding.
  • Raleigh Capital Management first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Raleigh Capital Management's Merck position peaked at $2.61M in Q2 2022.
  • 1,038 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.